A tale of two T-cells

A disclaimer: I'm not a pathologist, and I doubt anyone reading this is a pathologist either. I don't assume that we will all understand pathology by the end of this blog. I'm merely using a pedestrian example to make an important point.

If I harp on some things more than others over at the lymphoma boards for supportgroups.com, there's generally a reason. Such is the case with the terrible difficulty faced by pathologists in making an accurate lymphoma diagnosis, and because of this, second opinions are an absolute MUST.

It's not enough for someone to peer through a slide and say "lymphoma!" In fact, in lymphoma, this is so inadequate as to be the same as doing nothing at all.

In lymphoma, unlike other cancers, the stage of the disease often plays second fiddle to the classification subtype. So when a swollen lymph node biopsy is examined, the most important question is … what subtype of lymphoma does this patient have?

Get it right, the patient receives the most appropriate treatment.

Get it wrong, and the patient is subjected to unnecessary, ineffective, and harmful treatments. Valuable time is lost.

MISDIAGNOSES BY THE NUMBERS

How often do they get it wrong? There is no hard data, but one estimate published in a respected journal some years ago put the annual number of misdiagnoses for all cancers at 150,000.

For lymphoma, B-cell lymphomas are generally considered to be much easier to accurately diagnose. However, according to Scott Kogan, MD, associate professor of laboratory medicine at the University of California-San Francisco, "In the world of hematopathology, T-cell lymphoma is the most difficult diagnosis."

In fact, in one study [1] when pathologists considered the morphology (shape, characteristics) of a T-cell lymphoma, their rate of agreement was just 34%. Using additional testing, the agreement rate went up to 76%.

SLIDE VS SLIDE

Behold, slides from two biopsies showing two distinct T-cell lymphoid cancers with very different treatment protocols and very different prognoses.

A is T-Cell Prolymphocytic Leukemia (TPLL), categorized as a peripheral t-cell lymphoma. Extremely rare, atrociously aggressive, and thoroughly deadly. Median survival time from diagnosis is seven months.

B is Sézary syndrome (SS), an advanced, chronic form of cutaneous t-cell lymphoma that, depending on when it's found, can be managed and treated (and rarely, cured).

Believe it or not, despite looking virtually the same to our eyes, these two t-cell lymphomas are unlikely to ever be confused with one another because a constellation of clinical and laboratory factors—not just a glimpse through a microscope—determine diagnosis, from physical exams to symptom check to laboratory techniques like flow cytometry, phenotyping, immunohistochemistry, and more.

These techniques tease a lymphoma cell into giving up its secrets. You don't need to understand how they work, what they do, nothing. But you do need to see to it that they're performed.

GOING THE EXTRA MILE

Going the extra mile in lymphoma diagnosis should be the norm, but that's not always the case. What if you had early-stage SS but were misdiagnosed as having TPLL? You would undergo a number of fairly worthless and toxic treatments, spend lots of time in and out of hospitals, and measure your life in months.

Sure, you'll be happy and surprised to find yourself still alive a year later. But that year has not been good—not just all the needless treatments: your SS has been progressing unabated. You've lost valuable time in getting to the SS early, and now your prognosis is poor, when it would have been good a year ago.

PAYING THE ULTIMATE PRICE

There is a price to pay for a misdiagnosed lymphoma, and it always comes out of the patient's pocket in one form or another.

If an oncologist gives you a diagnosis of a T-cell lymphoma that hasn't been properly reviewed, they should urge a second opinion, especially if the original diagnosis was not made by a blood pathologist or a similar specialist at a designated cancer research center.

If they don't, find another doctor.

By Ross Bonander

[1] Zucca et al. (September 1998). "Management of rare forms of lymphoma." Curr Opin Oncol 10 (5):377-84. PMID 9800105.

Blog Category: 

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...